On September 13th, journalist Vivienne Parry interviewed InMed Pharmaceuticals’ President and CEO, Eric A. Adams, and BayMedica’s co-founder, Shane Johnson. In their first interview together, Eric and Shane talked about the acquisition and their shared vision of the combined company.
Gene Online Article: InMed Pharmaceuticals’ Positive Market Response to Cannabinoid Analog INM-901 for Alzheimer’s Treatment
In this article published in Gene Online September 4, 2024, reporter Bernice Lottering writes about InMed’s INM-901 Alzheimer’s disease preclinical study results and the company’s